Mr Vossenaar brings more than 25 years of experience in developing and leading life and health science commercial teams, having worked for large and small companies such as Amersham Bioscience, GE Healthcare, Stratagene, Agilent Technologies and most recently Hill-Rom International.

“We are delighted to welcome Mark to the team.” said Dan Calvo, CEO of Gyros Protein Technologies. “His proven leadership abilities and track record of implementing sales and operations strategies will help us continue to drive growth in the European market.”

Mark Vossenaar commented: “I am excited to join Gyros Protein Technologies and look forward to working with Dan and my new colleagues to achieve the company’s financial and strategic objectives”.

Established in March 2016 by the merger of Gyros AB and Protein Technologies, Inc., Gyros Protein Technologies combines Gyros’ microfluidics, systems development and immunoassay expertise with Protein Technologies’ deep knowledge in developing and manufacturing instruments for peptide synthesis. The Company provides customers an unrivaled range of peptide synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing.